Simplex Trading’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47K | Sell |
5,555
-10,647
| -66% | -$101K | ﹤0.01% | 5944 |
|
|
2025
Q4 | $197K | Sell |
16,202
-1,258
| -7% | -$15.3K | ﹤0.01% | 4251 |
|
|
2025
Q3 | $204K | Sell |
17,460
-44,118
| -72% | -$528K | ﹤0.01% | 4916 |
|
|
2025
Q2 | $571K | Buy |
61,578
+11,616
| +23% | +$90.9K | ﹤0.01% | 3360 |
|
|
2025
Q1 | $366K | Sell |
49,962
-43,511
| -47% | -$334K | ﹤0.01% | 3737 |
|
|
2024
Q4 | $798K | Buy |
93,473
+84,431
| +934% | +$824K | ﹤0.01% | 3070 |
|
|
2024
Q3 | $78K | Sell |
9,042
-13,900
| -61% | -$115K | ﹤0.01% | 5469 |
|
|
2024
Q2 | $156K | Sell |
22,942
-10,899
| -32% | -$67.3K | ﹤0.01% | 4903 |
|
|
2024
Q1 | $307K | Sell |
33,841
-25,274
| -43% | -$179K | ﹤0.01% | 4363 |
|
|
2023
Q4 | $263K | Buy |
+59,115
| New | +$175K | ﹤0.01% | 4377 |
|
|
2023
Q3 | – | Sell |
-142,822
| Closed | -$584K | – | 9484 |
|
|
2023
Q2 | $736K | Sell |
142,822
-1,208
| -0.8% | -$7.18K | ﹤0.01% | 2902 |
|
|
2023
Q1 | $759K | Buy |
144,030
+122,551
| +571% | +$582K | ﹤0.01% | 2851 |
|
|
2022
Q4 | $60K | Sell |
21,479
-29,906
| -58% | -$99K | ﹤0.01% | 5647 |
|
|
2022
Q3 | $213K | Buy |
51,385
+30,108
| +142% | +$152K | ﹤0.01% | 4527 |
|
|
2022
Q2 | $85K | Buy |
21,277
+16,468
| +342% | +$62.2K | ﹤0.01% | 5784 |
|
|
2022
Q1 | $23K | Sell |
4,809
-13,488
| -74% | -$74.8K | ﹤0.01% | 8096 |
|
|
2021
Q4 | $127K | Sell |
18,297
-12,709
| -41% | -$98.7K | ﹤0.01% | 5874 |
|
|
2021
Q3 | $444K | Buy |
31,006
+2,705
| +10% | +$30.4K | ﹤0.01% | 4275 |
|
|
2021
Q2 | $401K | Sell |
28,301
-5,549
| -16% | -$84.4K | ﹤0.01% | 4507 |
|
|
2021
Q1 | $0 | Sell |
33,850
-6,243
| -16% | -$120K | ﹤0.01% | 9669 |
|
|
2020
Q4 | $829K | Buy |
40,093
+35,574
| +787% | +$528K | ﹤0.01% | 2796 |
|
|
2020
Q3 | $34K | Sell |
4,519
-28,429
| -86% | -$236K | ﹤0.01% | 5964 |
|
|
2020
Q2 | $274K | Buy |
32,948
+24,521
| +291% | +$163K | ﹤0.01% | 3632 |
|
|
2020
Q1 | $41K | Sell |
8,427
-35,110
| -81% | -$173K | ﹤0.01% | 5333 |
|
|
2019
Q4 | $171K | Buy |
43,537
+23,192
| +114% | +$80.6K | ﹤0.01% | 3932 |
|
|
2019
Q3 | $61K | Sell |
20,345
-70,173
| -78% | -$314K | ﹤0.01% | 4821 |
|
|
2019
Q2 | $398K | Buy |
+90,518
| New | +$335K | ﹤0.01% | 2799 |
|
|
2019
Q1 | – | Sell |
-7,493
| Closed | -$30.1K | – | 7637 |
|
|
2018
Q4 | $29K | Sell |
7,493
-12,959
| -63% | -$71.4K | ﹤0.01% | 5026 |
|
|
2018
Q3 | $140K | Buy |
+20,452
| New | +$128K | ﹤0.01% | 4057 |
|
|
2017
Q4 | – | Sell |
-1,927
| Closed | -$9.84K | – | 6462 |
|
|
2017
Q3 | $11K | Buy |
+1,927
| New | +$12.4K | ﹤0.01% | 3693 |
|
|
2017
Q1 | – | Sell |
-11,557
| Closed | -$96.2K | – | 6599 |
|
|
2016
Q4 | $96K | Buy |
+11,557
| New | +$89.6K | 0.01% | 1569 |
|
|
2016
Q3 | – | Sell |
-9,574
| Closed | -$58.4K | – | 6263 |
|
|
2016
Q2 | $47K | Buy |
+9,574
| New | +$94.9K | ﹤0.01% | 2123 |
|
|
2016
Q1 | – | Sell |
-4,810
| Closed | -$36.4K | – | 6038 |
|
|
2015
Q4 | $45K | Buy |
4,810
+4,295
| +834% | +$46.4K | ﹤0.01% | 1999 |
|
|
2015
Q3 | $7K | Buy |
+515
| New | +$10.3K | ﹤0.01% | 3750 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
Simplex Trading's OCUL Position: Q1 2026 in Review
Simplex Trading reduced its Ocular Therapeutix (OCUL) stake by 66% in Q1 2026, selling an estimated $101K and leaving 5,555 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #5944.
Simplex Trading first reported a position in OCUL in Q3 2015 and has held it in 34 quarters since. The position peaked at $829K in Q4 2020. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.
- Simplex Trading held 5,555 shares of Ocular Therapeutix worth $47K as of Q1 2026.
- Simplex Trading sold 10,647 Ocular Therapeutix shares in Q1 2026, an estimated $101K.
- Ocular Therapeutix made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5944 holding.
- Simplex Trading first reported a position in Ocular Therapeutix in Q3 2015 and has held it in 34 quarters since.
- Simplex Trading's Ocular Therapeutix position peaked at $829K in Q4 2020.
- 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.